Ming Xiang Xu

Ming Xiang Xu


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2013 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
QZQuan Zhang
Quan Zhang
XXXiaoshuang Xu
Xiaoshuang Xu
YYYan Yuan
Yan Yuan
XGXiaocheng Gong
Xiaocheng Gong
ZCZedong Chen
Zedong Chen
MXMing Xiang Xu
Ming Xiang Xu
Inactivated Sendai virus (HVJ-E) directly kills cancer cells by inducing apoptosis through a mechanism mediated by Janus kinases/signal transducers and activators of transcription (JAK/STAT) signaling pathways. However, whether other signaling pathways are involved remain largely unknown. This study aimed to investigate the mechanism underlying HVJ-E–induced apoptosis in murine B16F10 melanoma cells. We found that HVJ-E induced B16F10 cell apoptosis via the caspase pathway, particularly caspase-9, which mediates the intrinsic apoptotic pathway. Mitogen-activated protein kinase (MAPK) pathway activation also contributed to HVJ-E–induced apoptosis. Whereas caspase pathway involvement depended on both IFN-β promoter stimulator-1 (IPS-1) and type I interferon (IFN), MAPK pathway activation was independent of type I IFN but involved IPS-1. In addition, intratumoral HVJ-E treatment displayed a direct oncolytic effect in an in vivo BALB/c nude mouse melanoma model. Collectively, our data provides new insights into the mechanism underlying HVJ-E–induced apoptosis in tumor cells.

11 October 2024 in Molecules
Verified
Journal Article
Open access
PDF file
YZYAO ZHAO
YAO ZHAO
SWShuai Wen
Shuai Wen
YWYan Wang
Yan Wang
WZWenshuo Zhang
Wenshuo Zhang
MXMing Xiang Xu
Ming Xiang Xu
YMYi Mou
Yi Mou
Cyanogenic glycosides are naturally occurring compounds found in numerous plant species, which can release toxic hydrogen cyanide upon hydrolysis. The quantification of cyanogenic glycosides is essential for assessing their potential toxicity and health risks associated with their consumption. Liquid chromatographic techniques coupled with various detectors have been widely used for the quantification of cyanogenic glycosides. In this review, we discuss recent advances in chromatographic quantification methods for cyanogenic glycosides, including the development of new stationary phases, innovative sample preparation methods, and the use of mass spectrometry. We also highlight the combination of chromatographic separation with mass spectrometric detection for the identification and quantification of specific cyanogenic glycosides and their metabolites in complex sample matrices. Lastly, we discuss the current challenges and future perspectives in the development of reliable reference standards, optimization of sample preparation methods, and establishment of robust quality control procedures. This review aims to provide an overview of recent advances in chromatographic quantification methods for cyanogenic glycosides and their applications in various matrices, including food products, biological fluids, and environmental samples.

9 February 2025 in ACS Omega
Verified
Journal Article
Open access
YMYi Mou
Yi Mou
YZYao Zhao
Yao Zhao
SWShuai Wen
Shuai Wen
XLXing Li
Xing Li
WZWenshuo Zhang
Wenshuo Zhang
燕王燕 王
燕 王
Imatinib mesylate has been identified as a tyrosine kinase inhibitor that selectively inhibits Abl tyrosine kinases, including Bcr-Abl. It exhibits many polymorphic forms, with the most stable and commercialized polymorphs known as the α and β forms. In the present study, the compatibility between the polymorphs of Imatinib mesylate and selected excipients (MCC, HPMC, PVPP, SiO2, MS, and CaHPO4) was investigated by differential scanning calorimetry (DSC), Raman spectra, X-ray diffraction (XRD) technique, and isothermal stress testing (IST). The results revealed that polymorph α of Imatinib mesylate has poor compatibility with selected excipients at high temperatures. As a contrary, polymorph β of Imatinib mesylate shows high compatibility with the selected excipients except MS under high temperatures.

2 March 2011 in Veterinary Immunology and Immunopathology
Verified
Journal Article
Closed access
QZQuan Zhang
Quan Zhang
ZWZhen Wang
Zhen Wang
YYYan Yuan
Yan Yuan
ZXZhengfeng Xue
Zhengfeng Xue
GZGuoqin Zhai
Guoqin Zhai
MXMing Xiang Xu
Ming Xiang Xu

8 March 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
YMYi Mou
Yi Mou
SWShuai Wen
Shuai Wen
YWYan Wang
Yan Wang
YZYAO ZHAO
YAO ZHAO
LLLi Ying-Ping Li
Li Ying-Ping Li
MXMing Xiang Xu
Ming Xiang Xu
The treatment of ulcerative colitis (UC) has been a major medical challenge due to the lack of safe and effective drugs. Molecular hybridization is a promising strategy for the development of drugs with pleiotropic activity, which has been demonstrated in a wide range of diseases. Tofacitinib has exhibited significant effects on the remission of UC, but a series of adverse effects have occurred during its clinical application. Herein, we propose to utilize a molecular hybridization strategy to link tofacitinib with a cytoprotective H2S donor (ADTOH) to obtain a series of hybridized molecules ZX-4C~ZX-6C. Among them, ZX-4C exhibited the best performance in the H2S release rate and the cytoprotective effects against dextran sulfate sodium (DSS)-induced injury. The in vivo studies showed that ZX-4C could effectively alleviate DSS-induced colitis by enhancing oxidative stress defense and reducing the inflammatory response, demonstrating that it is more potent than the parent drugs. The data from the present study support that this molecular hybridization strategy provides a promising avenue for the treatment of UC.

1 October 2012
Verified
Journal Article
Closed access
PDF file
QZQuan Zhang
Quan Zhang
YFYuan Wei Feng
Yuan Wei Feng
ZQZhai Guo Qin
Zhai Guo Qin
ZYZhu Shan Yuan
Zhu Shan Yuan
XFXue Zheng Feng
Xue Zheng Feng
MXMing Xiang Xu
Ming Xiang Xu